1. Antibody-Based Immunotoxins for Colorectal Cancer Therapy
   Laura Sanz et al, 2021, Biomedicines CrossRef
2. Cyclosporin A Enhance the Cytotoxicity of Immunotoxin to the HER-2-Overexpressing SK-OV-3 Cells: A Prospective Study
   Huilong Xie et al, 2024, Revista Brasileira de Farmacognosia CrossRef
3. Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective
   Mengyu Li et al, 2022, Antibody Therapeutics CrossRef
4. Nanobodies Enhancing Cancer Visualization, Diagnosis and Therapeutics
   Dhaneshree Bestinee Naidoo et al, 2021, International Journal of Molecular Sciences CrossRef
5. Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies
   Rajan K. Tripathy et al, 2024, Life Sciences CrossRef
6. DT389-YP7, a Recombinant Immunotoxin against Glypican-3 That Inhibits Hepatocellular Cancer Cells: An In Vitro Study
   Hamid Hashemi Yeganeh et al, 2021, Toxins CrossRef
7. Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment
   Javier Narbona et al, 2023, Biomolecules CrossRef
8. Emerging trends in immunotoxin targeting cancer stem cells
   Belay Zeleke Sibuh et al, 2022, Toxicology in Vitro CrossRef